Ario Pharma Ltd, a developer of drugs for the treatment of respiratory indications, has acquired the transient receptor potential cation channel, subfamily A, member ## (TRPA##) antagonist research program from PharmEste Srl, a biopharmaceutical company.
All Rights Reserved No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form by any means, electronic, mechanical, photocopying, recording or otherwise, without the prior permission of the publisher, GlobalData
Summary
Table of Contents
Search Inside
Ario Pharma Ltd is a drug development company that offers respiratory drugs.The company offers development of drugs for the treatment of respiratory indications.
It affords development services including preclinical studies, phase level studies and approval programs.Ario offers development of TPRV and TPRA drugs.
The company's TPRV drugs offer ion channel known to play an active role in controlling airway vagal sensory nerve activation and the cough reflex.Its TPRA drugs provide orally available therapeutic offering both multiple-symptomatic relief and, most importantly, disease modification, for longer term control of asthma.
Ario is based in Cambridge, the UK.
Ario Pharma Ltd - Pharmaceuticals & Healthcare - Transactions and Alliances Profile offers you detailled data and trend analysis of the company's Mergers and Acquisitions, alliances and financings.The study offers exhaustive data on Private Equity, Mergers and Acquisitions, Venture Financing, Equity/Debt Offerings, Venture Financing and Partnership transactions reported by the firm over a 5-year period.
The study provides extensive comparative data on: number of transactions, their values -subdivided into transactions types-, sub-sectors and areas.
GlobalData used data coming from Pharma eTrack deals database, primary and secondary research.
- Financial transactions - Analysis of the company's financial transactions including mergers and Acquisitions, Equity/Corporate debt offerings, Private equity investment, Venture capital financing and Alliances.
- Transactions by Year - Chart and table displaying information including the number of transactions and value described by the company by year, for a five year period.
- Transactions by Category - Chart and table depicting info containing the number of business deals and value announced by the company by type including Mergers and Acquisitions, Equity/Corporate debt offering etc.
- Transactions by Region - Chart and table presenting data on the number of accords and value described by the company by region, which comprises North America continent, Europe (EU), Asia Pacific (APAC), the Middle East (ME) and African continent and South and Central America.
- Transactions by Sub-sector - Chart and table showing data on the number of transactions and value announced by the company, by sub-sector.
- Main deals - Data on the company's main financial deals. Each such deal has a short statement, business deal type, deal justification; and deal financials and target company's main financial metrics and ratios.
- Business overview - A succinct description of the company's opertations.
- Main employees - A list of the main executives of the company.
- Significant locations and Subsidiaries - An inventory and contact details of main centers of operation and key partners (subsidiaries of the company).
- Main competitors - A list of the main competitors of the company.
- Main new developments - A succinct on latest news about the company.
Access comprehensive data on the company's financial transactions, company's expansion and divestiture and fund requirements
- The industry profile allows you to examine the company's financial transactions by region, by year, by industry segments and by category, for a five year period.
Gain knowledge on the growth and disinvestment strategy of the company
- The industry profile unveils transactions from the firm's core business segments' perspective to benefit you comprehend its business strategy.
Understand the main deals of the company with an overview of the recent financial transactions
- In-depth information on main recent deals includes a short statement of each deal, business deal type, deal motivation, financial deals and Target company's main financial metrics and ratios.
Get access to comprehensive data about the company's operations and detect potential clients and suppliers.
- The industry profile examines the corporate's business structure, areas and subsidiaries, main executives and key players.
Stay updated on main improvements affecting the firm
- Recent evolutions about the company exhibited in the profile advice you track main events.
Gain key aspects into the company for academic purposes or business purposes
- Highlight elements such as break up of transactions into types and info on detailed main deals are included into the industry profile to help your academic or business needs.
Note*: Some parts may be removed if info is not available for the company.This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 24h.
Get Industry Insights. Simply.
The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.
Kate Merrick
Global Marketing Manager at
Eurotherm by Schneider Electric
We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.
Category Manager at
Ikea
ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.
Executive Director at
PwC Advisory
The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!
Scott Griffith
Vice President Marketing at
Maurice Sporting Goods
The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research
Jessica P Huffman
Research Associate at
American Transportation Research Institute
Excellent customer service. Very responsive and fast.
Director, Corporate Strategy at
Ingredion
I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.
Mariana Mendoza
Global Platform Senior Manager at
Whirlpool Corporation
Thanks! I like what you've provided and will certainly come back if I need to do further research works.
Bee Hin Png
CEO at
LDR Pte Ltd
The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.
Kate Merrick
Global Marketing Manager at
Eurotherm by Schneider Electric
We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.
PTC Therapeutics, Inc.: Financial Highlights
PTC Therapeutics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment ReportSummaryMarketline’s PTC Therapeutics, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances ...
Onxeo SA: Financial Highlights
Onxeo SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment ReportSummaryMarketline’s Onxeo SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes ...
Myriad Genetics, Inc.: Financial Highlights
Myriad Genetics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment ReportSummaryMarketline’s Myriad Genetics, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and ...
Shanghai Fosun Pharmaceutical (Group) Co., ... $ 350 May 2018
ProMetic Life Sciences Inc.: Financial Hig ... $ 350 May 2018
Solvay Group: Financial Highlights $ 350 May 2018
Mitsubishi Tanabe Pharma Corporation: Fina ... $ 350 May 2018
ImmunoGen, Inc.: Financial Highlights $ 350 May 2018
Five Prime Therapeutics, Inc.: Financial H ... $ 350 May 2018
Bayer AG: Financial Highlights $ 350 May 2018
More Reports:
Pharmaceutical in the United States (3468)
Pharmaceutical in the World (6535)
Pharmaceutical in China (732)
Pharmaceutical in Japan (455)
Pharmaceutical in Europe (452)
Pharmaceutical in India (450)
Incyte Corporation - Analyst Report, July 2018
Therapy
Therapy
United States
Dr. Reddy's Laboratories Limited - Company Report, July 2018
Gastrointestina...
OTC
United States
India
North America
Concordia Healthcare Corp. - Analyst Report, July 2018
Pharmaceutical
Canada
Eli Lilly & Co. - Analyst Report, July 2018 3 days ago
More Reports:
Pharmaceutical in the United States (8950)
Pharmaceutical in the World (2490)
Pharmaceutical in Australia (1395)
Pharmaceutical in India (1369)
Pharmaceutical in Canada (1239)
Pharmaceutical in Europe (1049)
Pharmaceutical in China (928)
Related Market Segments :
ref:plp2018
Reportlinker.com © Copyright 2018. All rights reserved.